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Abstract
A novel, selective and sensitive single-ion monitoring (SIM) gas chromatography-mass
spectrometry (GCMS) method was developed and validated for the determination of energy
metabolites related to glycolysis, the tricarboxylic acid (TCA) cycle, glutaminolysis, and fatty
acid β-oxidation. This assay used N-tert-butyldimethylsilyl-N-methyltrifluoroacetamide
(MTBSTFA) containing 1% tert-butyldimethylchlorosilane (TBDMCS) as derivatizing
reagent and was highly reproducible, sensitive, specific and robust. The assay was used to
analyze liver tissue and serum from C57BL/6N obese mice fed a high-fat diet (HFD) and
C57BL/6N mice fed normal chow for 8 weeks. HFD-fed mice serum displayed statistically
significantly reduced concentrations of pyruvate, citrate, succinate, fumarate, and 2-oxoglu-
tarate, with an elevated concentration of pantothenic acid. In liver tissue, HFD-fed mice
exhibited depressed levels of glycolysis end-products pyruvate and lactate, glutamate, and
the TCA cycle intermediates citrate, succinate, fumarate, malate, and oxaloacetate. Panto-
thenate levels were 3-fold elevated accompanied by a modest increased gene expression
of Scl5a6 that encodes the pantothenate transporter SLC5A6. Since both glucose and fatty
acids inhibit coenzyme A synthesis from pantothenate, it was concluded that these data
were consistent with downregulated fatty acid β-oxidation, glutaminolysis, glycolysis, and
TCA cycle activity, due to impaired anaplerosis. The novel SIM GCMS assay provided new
insights into metabolic effects of HFD in mice.
Introduction
In recent years, obesity has become a serious worldwide health concern [1]. Chronic diseases
like cancer, cardiovascular disease, steatohepatitis and type 2 diabetes mellitus (insulin resis-
tance) are commonly associated with obesity [2]. Complex interactions of both genetic and
environmental factors with excessive fat accumulation are responsible for obesity development
[3–5]. There is no safe and effective drug therapy as obesity due to a chronic imbalance
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between energy intake and expenditure [6]. Therefore, mechanistic aspects of obesity develop-
ment have become the focus of many investigations, specifically using system biological
approaches.
Omics studies revealed that the development of obesity is accompanied by changes in mul-
tiple metabolic pathways such as the TCA cycle, fatty acid redox metabolism and glycolysis
[4,7–9]. Genomic and transcriptomic studies revealed that a number of genes are associated
with common human obesity development, with their functions involving hormone regula-
tions and insulin signaling, energy homeostasis, lipogenesis [7], nicotinamide phosphorylation
and inflammation and fatty acid β-oxidation in rodents [7]. Proteomic studies revealed that
obesity is associated with significant differential expression of proteins in adipose tissue, mus-
cle and liver [8], and serum [10] and alterations involving mitochondrial, cytoskeletal and
structural proteins together with TCP1 complex proteins [9].
Metabolomic studies have been reported to explore the obesity effects on HFD-induced
obese rodents [11–13] and for human obesity [10,14]. These studies revealed that obese mam-
mals have clearly different phenotypes and metabotypes of the metabolism of fatty acids,
amino acids, acylcholines, as well as for glycolysis and the TCA cycle [10–22]. Moreover, the
gut microbiota have significant roles to play in HFD-induced obesity in terms of energy har-
vest [3,23], insulin resistance [24], and modulations to host metabolisms [25,26]. However,
these previous studies provided limited information on the dynamic metabolic changes associ-
ated with the development of obesity they mostly focused on the consequences while the
dynamic processes of obesity development remain to be revealed.
The HFD-induced mouse obesity model resembles human obesity in phenotype and in its
complications [27]. Therefore, the role of TCA cycle intermediates, fatty acids, amino acids
and other metabolism associated pathways in obesity development may be examined in HFD-
fed mice using targeted metabolomics. Targeted metabolomics detects and quantitates varia-
tions in endogenous and exogenous metabolite composition for an integrated biological sys-
tem. Typically, GCMS, liquid chromatography-tandem mass spectrometry (LCMS/MS), and
nuclear magnetic response (NMR) are employed. These methodologies are useful to explain
the detailed metabolic adaptations associated with obesity development and have been success-
fully applied to reveal the biochemical aspects of metabolic disorders [28,29].
In this study, we sought to understand if the energy metabolites involved in glycolysis, the
TCA cycle, glutaminolysis, and fatty acid β-oxidation were altered in C57BL/6J obese mice
that had been fed a HFD. To accomplish this, a novel, specific and sensitive GCMS assay for
energy metabolites was developed that covered 13 TCA cycle and accessory metabolites.
Materials and methods
Animal studies and sample collection
Mouse experimental procedures, performed according to the National Institutes of Health
guidelines, were reviewed and approved by the National Cancer Institute Animal Care and
Use Committee. Mice were treated humanely and with regard for the alleviation of suffering.
Male 6- to 8-week-old mice on a C57BL/6N background were purchased from Charles River
Laboratories (Wilmington, MA) and individually housed in their home cages in a specific
pathogen-free environment controlled for temperature and light (25˚C, 12h light: 12h dark
cycle), and humidity (45–65%), with ad libitum access to water and pelleted NIH-31 chow. All
mice were randomly assigned to experimental groups. Study group and control group mice
showed no difference in body weight gain before treatment. Obesity was induced in male 6–8
week-old wild-type mice (study group) by feeding a HFD (60% Kcal from fat; Bio-Serv, Fle-
mington, NJ) or NIH-31 diet (control group) for 8 weeks. Mice were weighed at weekly
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intervals and the HFD-fed mice gained three-times more body weight than the control chow-
fed mice (Fig 1). At the end of the study, all animals were fasted for 12 h prior to being eutha-
nized by CO2 asphyxiation. Blood samples and liver were collected at the end of study from
each group for metabolic analysis. All remaining samples were snap-frozen using liquid nitro-
gen immediately after collection and stored at -80˚C until further analysis.
Chemicals and materials
All metabolite standards (> 98%) and D,L-norleucine (DLN; internal standard) (> 99%) were
purchased from Sigma-Aldrich (St. Louis, MO). The derivatization reagent MTBSTFA + 1%
TBDMCS (N-tert-butyldimethylsilyl-N-methyltrifluoroacetamide with 1% tert-butyldimethyl
chlorosilane) was purchased from Regis Technologies Inc. (Morton Grove, IL). BSTFA (N,O-
bis(trimethylsilyl)trifluoroacetamide) was purchased from Sigma-Aldrich. LCMS grade aceto-
nitrile was purchased from Fisher Scientific (Waltham, MA). Deionized water was obtained
from Milli-Q water purification system from EMD Millipore (Billerica, MA).
Chromatographic and mass detection parameters
Silylated derivatives of energy metabolites were separated on a capillary column (30 m × 0.250
mm, 0.25 μm; Agilent Technologies, Foster City, CA). Analyses were performed with an Agi-
lent 6890N gas chromatograph coupled to an Agilent 5973 mass-selective detector (MSD) with
following chromatographic conditions: Initial temperature 50˚C for 2 min, increasing to
150˚C at 20˚C/min over 5 min and finally to 300˚C at 8˚C/min for 20 min. The front inlet tem-
perature was 250˚C operating with a split ratio of 1:25. MSD ion source and interface tempera-
ture was 280˚C. The MSD operated in EI mode at 70 eV. SIM mode of 30–650 m/z was used
for the analyses. Carrier gas was He (1.0 ml/min). GCMS data were acquired and processed
using Agilent MassHunter WorkStation software.
Fig 1. Body weight gain for mice fed HFD diet and control chow over 8 weeks. **** p < 0.0001.
https://doi.org/10.1371/journal.pone.0177953.g001
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Calibration standards and quality control samples
Standard stock solutions of energy metabolites (5.0 mM) were prepared in acetonitrile. Fur-
ther, working solutions were prepared using intermediate solutions of 500.0 μM and 50.0 μM
in acetonitrile:water (50:50 v/v). Calibration curve standards were made at 0.5, 2.0, 5.0, 10, 25,
50 μM, while the quality control samples were prepared at four levels, that is, 40 μM (HQC,
high quality control), 20 μM (MQC, middle quality control), 7.5 μM (LQC, low quality con-
trol), 0.5 μM (LLOQ QC, lower limit of quantitation quality control). A stock solution of the
internal standard (2.0 mM, DLN) was used. Further, working solutions were prepared from
the stock solution in acetonitrile:water (50:50 v/v) at 10.0 μM for DLN.
Preparation of liver samples
C57BL/6N mouse liver tissue 20 ± 0.05 mg (chow and HFD diet-fed) was placed in 0.7 ml 70%
acetonitrile:water (70:30 v/v) and 20 μl of DLN (IS,10μM) added, followed by homogenization
using a Precellys homogenizer (Bertin Instruments, Montigny-le-Bretonneux, France), utilizing
1.0 mm zirconia/silica beads for 30 sec at 6500 rpm. The samples were centrifuged at 20,000g
for 10 min at 4˚C and 600 μl of supernatant was taken and dried in a SpeedVac concentrator at
room temperature. The dried residue was derivatized by adding 50 μl MTBSTFA + 1% TBDMCS,
and sonicated for 30 min at room temperature. The samples were diluted with 50 μμl acetonitrile,
briefly vortexed for 10 s and 1.00 μl was injected into the GCMS using an autosampler. It was
found that neither isocitric acid nor pantothenic acid derivatized well with MTBSTFA + TBDMCS
and therefore these compounds were determined in liver as above, only using BSTFA (50 μl) with
30 min sonication at room temperature. After dilution with 50 μl acetonitrile, samples were briefly
vortexed for 10 s and 1.00 μl analyzed as above by GCMS.
Preparation of serum samples
To an aliquot of 50 μl serum, 20 μl of DLN (10μM) was added, the sample vortexed for 10 s,
and 0.7 ml of acetonitrile added and vortex mixed for a further 1 min. The samples were cen-
trifuged at 20,000g for 10 min at 4˚C and 0.6 ml supernatant transferred to 2 ml vials. The
samples were dried in a SpeedVac concentrator at room temperature and the dried residue
derivatized with using 50 μl MTBSTFA + 1% TBDMCS. The samples were sonicated for 30
min at room temperature and diluted with 50 μl acetonitrile, briefly vortexed for 10 s and
1.00 μl was injected into the GCMS using an autosampler. For the analysis of isocitric acid and
pantothenic acid, dried residues were derivatized as for liver tissue extracts using N,O-bis(tri-
methylsilyl)trifluoroacetamide (BSTFA).
Validation procedures
Three calibration curves were plotted covering the range of 0.05–50μM for TCA intermediates
using least squares regression and 1/x2 as a weighting factor. The area response ratio for ana-
lyte/IS obtained from single ion monitoring was used for regression analysis. The acceptance
criterion for a calibration curve was a correlation coefficient (r2) 0.99 and the lowest stan-
dard on the calibration curve was accepted as the assay sensitivity expressed as LLOQ. Intra-
batch accuracy and precision was determined by analyzing six replicates of QC samples along
with calibration curve standards on the same day, while the inter-batch accuracy and precision
were assessed by analyzing three precision and accuracy batches on three consecutive days.
The precision (% CV) at each concentration level from the nominal concentration was
expected to be not greater than 15% and the accuracy to be within ±15% as per USFDA
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guidelines [30], except for the LLOQ where it can be 80–120% of the nominal concentration.
Reinjection reproducibility was also checked by re-injecting one entire validation batch.
Stability tests were conducted for stock solutions of analytes and ISs for short term and long
term stability at 18˚C and 4˚C respectively. All stability results for spiked samples were evalu-
ated by measuring the area response ratio (analyte/IS) of stability samples against freshly pre-
pared comparison standards. QC samples at HQC and LQC levels were prepared to check for
bench top, autosampler (wet extract), processed sample, dry extract, freeze-thaw and long
term (-80˚C) stability. The acceptance criterion was ± 10.0% deviation (from the nominal
value) for stock solutions and ± 15% deviation for all other storage conditions.
RNA extraction and qPCR analysis
mRNA was prepared from frozen mouse liver as described [31]. Gene expression for Slc5a6
and Gapdh was analyzed by qPCR using SYBR1 GreenER™ Reagent System (Invitrogen,
Carlsbad, CA) in a 7900 HT Fast Real-Time PCR system (Applied Biosystems, Carlsbad, CA).
Relative expression calculated by the ΔΔCt method using Gapdh mRNA as the internal control,
and statistical analyses were performed using the ΔCt values. Primer sequences for gene
expression analyses are available on request.
Statistical analysis
Energy metabolites were estimated by non-compartmental analysis using MassHunter Work-
station Software Quantitative Analysis Version B.05.01 (Agilent Technologies). Group differ-
ences were evaluated with a nonparametric two-tailed Mann-Whitney U test using GraphPad
Prism 6 (San Diego, CA). Experimental values are presented as mean ± S.D.
Results
GCMS assay development
Published methods for the simultaneously determination of energy metabolites using GCMS,
LC-MS/MS or NMR suffer from either cumbersome extraction procedures, long retention
times or low sensitivity. The first aim of this study was to develop a rugged GCMS method that
offered the combined advantage of sensitivity, selectively, simplicity of extraction procedure,
and high throughput, adequately controlled for potential errors during extraction and analysis,
thereby ensuring accuracy of the generated data. Mass spectrometry parameters were opti-
mized to maximize the response for the energy metabolites and IS represented in Table 1. The
full scan spectra showed consistent and predominant target and qualifier ions for energy
metabolites with NIST mass spectral library matches (86–99%) as shown in Table 1. The elec-
tron ionization mass spectra under optimized conditions for the TCA metabolites and IS are
presented in Fig 2. The most stable and consistent fragment ions for the TBDMS derivatives of
pyruvic acid, citric acid, cis-aconitic acid, 2-oxoglutaric acid, succinic acid, fumaric acid, malic
acid, oxaloacetic acid, lactic acid, glutamine, glutamic acid, isocitric acid, pantothenic acid,
and DLN (IS) were observed at m/z 139, 459, 459, 431, 289, 287, 419, 417, 147, 73, 73, 273
(TMS derivative), 73 (TMS derivative), and 200, respectively.
In the present study, several trials were carried out on tissue and serum with different
extraction techniques, namely protein precipitation (PP) and liquid-liquid extraction (LLE)
followed by use of different silylation reagents. The serum PP was extracted using methanol
and acetonitrile as protein precipitants; however, with methanol the recovery showed
poor chromatography with high variability of the IS (50–70%) at LLOQ and LQC levels for
malic acid, oxaloacetic acid and 2-oxoglutaric acid. Thus, acetonitrile was used for protein
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Table 1. Quantitation by GCMS of energy metabolites.






Limit of detection (μM) System suitability
(%CV)
(n = 6)
Pyruvic acid 139 259,189 10.1 86 0.03 1.18
Citric acid 459 357,591 22.7 99 0.20 1.45
Cis-aconitic acid 459 327,501 20.2 97 0.03 2.09
2-Oxoglutaric acid 431 375,473 18.7 98 0.20 3.92
Succinic acid 289 278,331 12.8 99 0.01 2.09
Fumaric acid 287 301,329 13.2 99 0.03 1.76
Malic acid 419 287,461 17.2 99 0.03 2.64
Oxaloacetic acid 417 389,459 17.4 91 0.01 4.42
Lactic acid 261 189,233 9.7 99 0.01 3.69
Glutamine 431 329,357 20.8 98 0.03 4.02
Glutamic acid 432 330,272 19.1 98 0.03 4.56
Isocitric acid 273 363,465 14.6 92 0.20 4.98
Pantothenic acid 291 201,247 15.9 94 0.03 3.84
D,L-Norleucine (IS) 200 274,302 12.7 99 — 3.69
%CV: Percent coefficient of variance.
https://doi.org/10.1371/journal.pone.0177953.t001
Fig 2. Mass spectra showing target and qualifier ions for a) pyruvic acid, b) succinic acid, c) fumaric acid, d) malic acid, e)
oxaloacetic acid, f) 2-oxoglutaric acid, g) citric acid, h) cis-aconitic acid, i) DL-norleucine (IS), j) pantothenic acid, k)
glutamine, l) glutamic acid, m) lactic acid, and n) isocitric acid. The metabolites j) and n) were derivatized with BSTFA, rather
than MTBSTFA + 1% TBDMCS.
https://doi.org/10.1371/journal.pone.0177953.g002
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precipitation before derivatization of the energy metabolites. Further, LLE was tested for liver
tissue samples with different organic diluents using dichloromethane, ethyl acetate, chloro-
form, n-hexane, alone and in combination under neutral and alkaline conditions. The results
showed very poor chromatography with high IS variability (65–80%) in almost all the solvents,
especially for LLOQ and LQC samples as most of the energy metabolites are highly water solu-
ble. Thus, monophasic liquid extraction was carried out on using 70% aqueous acetonitrile to
overcome the problems encountered during LLE.
Previous methods have used N,O-bis-(trimethylsilyl)acetamide (BSA) [32], N-trimethylsi-
lyl-N-methyl trifluoroacetamide (MSTFA) [33], BSTFA and trimethylchlorosilane (TMCS)
[34], tributylamine [35], derivatizing reagents with a longer analysis time [35] and lower sensi-
tivity [34] for selected energy metabolites [33,36] analyzed by GCMS [34,36] and LCMS
[33,35] (S1 Table). A major lacuna in even the most recently published methods is metabolite
coverage. Our method quantitates 13 TCA and accessory metabolites (Table 2), while the most
recent reports using BSTFA + 1% TCMS quantitated only 7/13 metabolites [37], and 6/13
metabolites [38], and using MSTFA quantitated only 3/13 metabolites [39]. This meager
metabolite coverage in recent published reports was a major factor in our assay development.
In addition, many published methods took an overly long time for the separation of analytes
under gradient elution and thus may not be useful for high-throughput analysis. Therefore,
different silylation reagents were evaluated, including, tert-butyldimethylsilyl (TBDMS),
BSTFA, MSTFA, and MTBSTFA + 1% TBDMCS. Among these, good chromatography was
observed and all energy metabolites could be quantitated with MTBSTFA + 1% TBDMCS,
except for isocitric acid and pantothenic acid. However, BSTFA was able to generate a stable
silyl derivative for these two metabolites. The principal limitation of this method was the fail-
ure to separate citric and isocitric acids on the column used. Nevertheless, MTBSTFA + 1%
TBDMCS was chosen as the derivatization reagent for the determination of energy metabolites
in serum and liver tissues because it gave better separation of analytes, with more stable deriva-
tives, which yielded characteristic [M-57]+ fragment ions [40,41] with a superior performance
than BSTFA for non-sterically-hindered substrates [41]. Table 2 shows the response ratios for
each of the energy metabolites determined in mouse serum and liver tissues after feeding HFD
and normal chow diet.
Table 2. The results of targeted TCA intermediates in serum and liver.
Energy metabolite Derivatization reagent Area response ratio
± S.D. (Liver, n = 5)
Area response ration ± S.D
(Serum, n = 5)
HFD CHOW HFD CHOW
Pyruvic acid MTBSTFA + 1%TBDMCS 0.013 ± 0.010 0.049 ± 0.019 1.22 x 10−4± 5.68 x 10−5 2.39 x 10−4 ± 3.24 x 10−5
Citric acid MTBSTFA + 1%TBDMCS 0.095 ± 0.100 0.293 ± 0.117 1.96 x 10−3± 4.30 x 10−4 2.92 x 10−3± 4.58 x 10−4
Cis-aconitic acid MTBSTFA + 1%TBDMCS 0.027 ± 0.014 0.043 ± 0.014 1.91 x 10−4± 1.42 x 10−4 4.47 x 10−4± 2.63 x 10−4
2-Oxoglutaric acid MTBSTFA + 1%TBDMCS 0.105 ± 0.031 0.221 ± 0.144 4.61 x 10−4± 1.36 x 10−4 1.20 x 10−3± 4.00 x 10−4
Succinic acid MTBSTFA + 1%TBDMCS 5.473 ± 2.041 17.981 ± 9.505 0.012 ± 0.002 0.024 ± 0.10
Fumaric acid MTBSTFA + 1%TBDMCS 0.364 ± 0.489 2.543 ± 0.554 4.92 x 10−3± 2.31 x 10−3 7.84 x 10−3± 2.85 x 10−3
Malic acid MTBSTFA + 1%TBDMCS 0.012 ± 0.005 0.946 ± 0.435 1.84 x 10−3± 2.97 x 10−4 2.82 x 10−3± 9.01 x 10−4
Oxaloacetic acid MTBSTFA + 1%TBDMCS 0.022 ± 0.016 0.119 ± 0.048 ND ND
Lactic acid MTBSTFA + 1%TBDMCS 3.149 ± 1.114 7.833 ± 2.376 0.894 ± 0.457 1.194 ± 0.276
Glutamine MTBSTFA + 1%TBDMCS 0.004 ± 0.004 0.004 ± 0.001 0.060 ± 0.011 0.027 ± 0.008
Glutamic acid MTBSTFA + 1%TBDMCS 0.257 ± 0.054 0.425 ± 0.090 ND ND
Isocitric acid BSTFA 0.399 ± 0.084 0.616 ± 0.125 3.138 ± 0.643 3.732 ± 0.435
Pantothenic acid BSTFA 0.145 ± 0.058 0.052 ± 0.012 0.602 ± 0.051 0.462 ± 0.035
https://doi.org/10.1371/journal.pone.0177953.t002
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For the optimum separation of analytes, several chromatographic parameters were investi-
gated, including the He gas flow and injection volume. Based upon the findings, 1 ml/min He
gas flow with 1.00 μl injection volume was chosen for further optimization based on peak
shape and response. The efficiency of sample cleanup and chromatography can be demon-
strated by flat baseline, with negligible influence of other endogenous components at the reten-
tion time of metabolites and IS (Fig 3).
The precision (%CV) system suitability test was with six consecutive injections of energy
metabolite standards (20 μM) with IS (10μM). The reinjection reproducibility in the measure-
ment of retention times for the analytes, expressed as % CV was 3.5 for 150 injections on the
same column. The limit of detection (LOD) and LLOQ of the method were 0.01–0.03 and
0.05 μM for energy metabolites (Table 1).
The three calibration curves were linear over the concentration range 0.5–50 μM for TCA
intermediates, with a correlation coefficient r2 0.99 for all analytes. The accuracy and preci-
sion (%CV) for the calibration curve standard ranged from 87–108% and 2.1–8.9%, respec-
tively. The intra-batch and inter-batch precision (%CV) varied 2.76–8.82 and the accuracy was
within 91.5–111% (Table 3).
Stock solutions kept for short periods (18 h) at room temperature and long-term storage
for 20 days at 4˚C, as well as freshly prepared solutions showed no evidence of degradation
under all studied conditions. No significant degradation was observed for energy metabolites
during sample storage and any of the processing steps during extraction. The detailed results
for stability studies are presented in Table 4. The precision values for method ruggedness were
4.1–9.1%. The ability to dilute samples which could be above the upper limit of the calibration
range was validated by analyzing six replicate samples containing 100 μM after five- to ten-fold
dilution. The precision (% CV) values for dilution reliability were 4.6–9.3.
Effect of high-fat diet on serum energy metabolites
Fig 4 shows analyte/IS ratios for 12 energy metabolites in mouse serum after HFD and control
chow diet feeding for 8 weeks to 8-week-old C56BL/6N mice. HFD fed mice clearly had statis-
tically significantly attenuated energy metabolites in serum, with pyruvate (Fig 4A; -49%), cit-
rate (Fig 4B; -37%), succinate (Fig 4D; -50%), fumarate (Fig 4E; -50%), and 2-oxoglutarate (Fig
4G; -60%) serum concentrations all reduced. Serum glutamine (Fig 4H) and pantothenic acid
(Fig 4L) were statistically significantly increased by 115% and 32%, respectively.
Effect of high-fat diet on hepatic energy metabolites
Fig 5 represents a schematic of the TCA cycle, with the liver levels of each intermediate shown
after HFD and control chow feeding for 8 weeks to 8-week-old C56BL/6N mice. In addition,
levels for pyruvate and lactate are also shown, since pyruvate is generated from glucose by
cytosolic glycolysis and enters the TCA cycle after conversion to acetyl-CoA. Glutamine is the
second major energy source after glucose, entering the TCA cycle after conversion to gluta-
mate by glutaminase and glutamate dehydrogenase to 2-oxoglutarate, As Fig 5 shows, hepatic
glutamine concentration was not affected by HFD, but the concentration of resulting gluta-
mate was impaired with HFD feeding. The findings shown in Fig 5 establish that HFD impairs
hepatic cytosolic glycolysis with a 64% and 62% reduction in hepatic pyruvate and lactate con-
centrations, respectively. Interestingly, hepatic pantothenic acid concentration was elevated
175% with HFD. Pantothenic acid is a vitamin and an obligatory precursor foe Coenzyme A
synthesis [42]. Pantothenic acid is imported to the cell by the sodium-dependent multivitamin
transporter SLC5A6 [43]. After HFD feeding, hepatic Slc5a6 gene expression was increased
+27% (Fig 5).
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Fig 3. Representative single ion monitoring chromatograms of the energy metabolites. a) pyruvic acid, b) succinic acid, c) fumaric acid, d) malic acid,
e) oxaloacetic acid, f) 2-oxoglutaric acid, g) cis-aconitic acid, h) citric acid, i) DL-norleucine (IS), j) lactic acid, k) glutamine, l) glutamic acid, m) isocitrate, and
n) pantothenic acid at MQC (20.0 μM).
https://doi.org/10.1371/journal.pone.0177953.g003
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The results show that the newly developed analytical method has the required sensitivity to
characterize the altered levels of energy metabolites in liver and serum after feeding HFD and
chow diet to mice for 8 weeks.
Discussion
The ability to measure serum and hepatic levels of TCA and accessory metabolites using the
newly developed assay demonstrates that HFD feeding to mice suppresses glycolysis,
Table 3. Intra- and inter-day precision and accuracy of quality control samples for targeted TCA metabolites.
TCA metabolite
(Nominal concentration)
Intra Quality Control Levels (Nominal Conc. (μM))
LLOQ QC (0.5 μM) LQC (7.5 μM) MQC (20.0 μM) HQC (40.0 μM)
A %CV % Accuracy A %CV % Accuracy A %CV % Accuracy A %CV % Accuracy
Pyruvic acid 0.52 5.54 105 7.91 4.85 106 21.6 8.23 108 44.4 8.54 111
Citric acid 0.48 7.71 95.7 7.57 6.35 101 19.8 2.68 99.2 42.0 7.04 105
Cis-aconitic acid 0.51 10.6 103 6.96 6.06 92.8 19.1 7.52 95.6 40.4 8.50 101
2-Oxoglutaric acid 0.52 8.59 104 7.07 8.03 94.3 19.7 9.46 98.7 39.4 6.10 98.5
Succinic acid 0.52 10.2 105 6.64 6.57 88.6 18.5 2.00 92.5 42.1 2.76 105
Fumaric acid 0.48 8.46 98.8 6.70 3.91 89.3 19.0 2.75 94.9 36.6 2.58 91.5
Malic acid 0.54 5.02 107 7.09 9.41 94.5 18.3 2.22 91.6 41.5 2.77 104
Oxaloacetic acid 0.52 8.79 104 7.23 7.19 96.5 19.4 5.24 97.2 38.1 3.22 95.2
TCA metabolite
(Nominal concentration)
Inter Quality Control Levels (Nominal Conc. (μM))
LLOQ QC (0.5 μM) LQC (7.5 μM) MQC (20.0 μM) HQC (40.0 μM)
A %CV % Accuracy A %CV % Accuracy A %CV % Accuracy A %CV % Accuracy
Pyruvic acid 0.52 8.36 105 7.46 6.13 99.5 20.1 8.22 100 40.1 8.82 100
Citric acid 0.49 7.56 99.0 7.24 7.79 97.4 19.0 6.06 95.0 38.5 5.71 96.2
Cis-aconitic acid 0.53 8.48 106 7.03 7.52 93.7 18.9 8.38 94.6 38.1 6.25 95.2
2-Oxoglutaric acid 0.49 7.45 98.8 7.11 9.32 94.9 20.6 5.25 103 41.3 5.52 103
Succinic acid 0.48 8.75 96.4 6.83 8.12 91.1 19.7 8.27 98.7 39.7 5.06 99.3
Fumaric acid 0.54 6.51 107 6.80 7.17 90.7 19.1 6.29 95.5 37.7 3.85 94.2
Malic acid 0.53 7.94 106 7.45 5.70 99.4 18.3 3.72 91.5 38.3 4.15 95.3
Oxaloacetic acid 0.52 6.42 103 7.75 6.09 103 19.8 6.11 98.8 38.8 3.17 97.0
A: Mean concentration (μM), %CV: Percent co-efficient of variance, LLOQ QC: Lower limit of quantitation quality control
LQC: Low quality control, MQC: Middle quality control, HQC: High quality control.
https://doi.org/10.1371/journal.pone.0177953.t003
Table 4. Stability values for targeted TCA intermediates under different conditions.






















LQC 5.75 8.24 7.25 -4.61 6.94 9.73 6.82 4.36
HQC -3.06 3.61 8.92 0.23 12.90 8.02 -5.97 -6.79
Auto sampler Stability;
75h at 25˚C
LQC 0.23 3.96 4.12 -3.24 0.68 6.15 4.48 3.06
HQC -0.41 2.65 6.71 5.35 9.76 8.20 0.61 -3.22
Dry Extract Stability;
32h at -70˚C
LQC -4.56 -4.84 -1.08 1.57 -4.90 9.32 -3.70 5.02
HQC -5.19 -0.88 7.81 6.07 10.32 8.73 5.77 3.68
Wet Extract Stability;
22h at 4˚C
LQC 0.02 9.78 6.61 -6.33 0.71 -0.03 11.50 -0.06
HQC 7.98 5.42 3.55 10.25 6.27 1.99 2.79 -5.88
% Change = (Mean stability samples–Mean comparison samples × 100)/ (Mean comparison samples).
n = Number of replicates for each level.
https://doi.org/10.1371/journal.pone.0177953.t004
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glutaminolysis and the TCA cycle. It is particularly notable that hepatic malate concentrations
were suppressed 100-fold by HFD feeding for 8 weeks. This will affect the production of
NADH by mitochondrial malate dehydrogenase. The malate-oxaloacetate shuttle serves to
transport reducing equivalents produced by cytosolic glycolysis into the mitochondrion, since
the mitochondrial inner membrane is impermeable to NADH. Malate produced from oxaloac-
etate + NADH in cytosol crosses into mitochondria where its reconversion to oxaloacetate
generates NADH, which can be used for ATP generation by oxidative phosphorylation [44].
The results shown here suggest that the malate-oxaloacetate shuttle is also impaired under
HFD feeding in mice. Hepatocytes would appear to have impaired energy production from
glucose and glutamine under HFD feeding. It is possible that the liver generates energy from
fatty acid β-oxidation (FAO), but this is an anaplerotic pathway that feeds the TCA cycle with
acetyl-CoA. This process requires coenzyme A (CoA), which is synthesized from the vitamin
pantothenic acid, and also cysteine and ATP [42]. As Fig 4 shows, hepatic pantothenic acid
Fig 4. Changes for the serum energy metabolite/IS ratios for HFD (H)- and control chow diet (C)-fed mice (n = 5). A,
pyruvic acid; B, citric acid; C, cis-aconitic acid; D, succinic acid; E, fumaric acid; F, malic acid; G, 2-oxoglutaric acid; H,
glutamine; I, glutamic acid; J, lactic acid; K, isocitric acid; L, pantothenic acid. *p<0.05; **p<0.01.
https://doi.org/10.1371/journal.pone.0177953.g004
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concentration was approx. three-fold enhanced after HFD feeding. Increases in both plasma
and urinary pantothenic acid have been reported for rats fed a HFD [45]. The increase
observed in this study may in part have been due to +27% increased expression of the Slc5a6
gene encoding the pantothenic acid transporter SLC5A6. However, this was a meager increase
compared to the much larger increase in hepatic pantothenic acid. It should be noted that the
rate-limiting step in CoA synthesis is the initial 4’-phosphorylation of pantothenic acid by pan-
tothenate kinase [42,46]. In isolated perfused rat hearts, pantothenate kinase was inhibited
both by glucose and palmitic acid [46], both of which are expected to be elevated in the liver
after HFD feeding. This perhaps better explains the +175% increase in hepatic pantothenic
acid, rather than the smaller +27% increase in Slc5a6 expression. Additionally, it should be
noted that serum pantothenic acid was statistically significantly increased by +32%. If HFD
induced hepatic Slc5a6 expression, it should similarly have induced intestinal Slc5a6 expres-
sion and therefore enhanced absorption of pantothenic acid from the diet. This is the most
likely scenario given that the manufacturers’ descriptions place pantothenic acid at 25 mg/kg
for the NIH-31 pelleted chow but only 5.5 mg/kg for the HFD soft pellets. Thus, elevated
serum pantothenic acid must have occurred secondary to massively increased absorption of
this dietary vitamin.
Overall, HFD feeding impaired TCA cycle intermediates, glycolytic end-products, and
glutamate, suggesting that anaplerosis was significantly decreased. In particular, the -68%
decrease in hepatic citrate indicates that there was no increased anaplerotic flux of acetyl-CoA
Fig 5. Representation of the TCA cycle and anaplerotic energy metabolites, showing metabolite levels after HFD
(H) and control chow (C) feeding to 8 week-old mice for 8 weeks. Ordinate axes represent metabolite peak area/IS
peak area, except for SLC5A6 expression (top right), where the ordinate represents mRNA expression.
https://doi.org/10.1371/journal.pone.0177953.g005
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into the TCA cycle due to enhanced FAO. Nor was the liver of these animals using protein as
an energy source because amino acids enter the TCA cycle after conversion to pyruvate (ala-
nine, serine, glycine, threonine, cysteine, tryptophan), oxaloacetate (aspartate, asparagine),
2-oxoglutarate (glutamate, glutamine, proline, histidine, arginine), fumarate (phenylalanine,
tyrosine), succinyl-CoA (methionine, isoleucine, valine), and acetyl-CoA (leucine, isoleucine,
lysine, phenylalanine, tyrosine, tryptophan, threonine) [47]. None of these gateways would
appear to be active after HFD feeding.
In conclusion, a highly reproducible SIM GCMS method was developed and for the simul-
taneous determination of energy metabolites after derivatization with MTBSTFA + 1%
TBDMCS, both for serum and tissue samples. The method offers several advantages over
reported procedures, in terms of sensitivity, lower sample requirements, a simple extraction
procedure and overall analysis time. The efficiency of monophasic liquid extraction for liver
tissue, protein precipitation for serum and a short chromatographic run time are highly favor-
able for high-throughput bioanalysis. Using this assay, analysis of serum and liver tissue from
mice fed HFD and a control chow diet permitted insights into hepatic energy metabolism.
Supporting information
S1 Fig. Typical total ion chromatograms for serum extracts. a) high-fat diet fed mouse
serum derivatized with MTBSTFA + 1% TBDMCS (see text), b) control chow fed mouse
serum derivatized with MTBSTFA + 1% TBDMCS, c) high-fat diet fed mouse serum deriva-
tized with BSTFA (see text), d) control chow fed mouse serum derivatized with BSTFA.
(TIF)
S2 Fig. Typical total ion chromatograms for liver extracts. a) high-fat diet fed mouse liver
derivatized with MTBSTFA + 1% TBDMCS, b) control chow fed mouse liver derivatized with
MTBSTFA + 1% TBDMCS, c) high-fat diet fed mouse liver derivatized with BSTFA, d) control
chow fed mouse liver derivatized with BSTFA.
(TIF)
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